Recombinant Human IFN-alpha H2/IFNA14 Protein, CF

Catalog # Availability Size / Price Qty
11019-IF-010
11019-IF-050
Recombinant Human IFN-alpha H2/IFNA14 Protein Binding Activity.
2 Images
Product Details
FAQs
Reviews

Recombinant Human IFN-alpha H2/IFNA14 Protein, CF Summary

Product Specifications

Purity
>95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
Endotoxin Level
<0.10 EU per 1 μg of the protein by the LAL method.
Activity
Measured in anti-viral assays using HeLa human cervical epithelial carcinoma cells infected with encephalomyocarditis (EMC) virus. Meager, A. (1987) in Lymphokines and Interferons, a Practical Approach. Clemens, M.J. et al. (eds): IRL Press. 129. The ED50 for this effect is 1.50-15.0 pg/mL.
Source
Human embryonic kidney cell, HEK293-derived IFN-alpha H2/IFNA14 protein
Cys24-Asp189
Accession #
N-terminal Sequence
Analysis
Cys24
Predicted Molecular Mass
20 kDa
SDS-PAGE
22-26 kDa, under reducing conditions.

Product Datasheets

You must select a language.

x

11019-IF

Carrier Free

What does CF mean?

CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.

What formulation is right for me?

In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.

11019-IF

Formulation Lyophilized from a 0.2 μm filtered solution in PBS.
Reconstitution Reconstitute at 100 μg/mL in PBS.
Shipping The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.

Scientific Data

Binding Activity View Larger

Recombinant Human IFN-alpha H2/IFNA14 (Catalog # 11019-IF) demonstrates anti-viral activity in HeLa human cervical epithelial carcinoma cells infected with encephalomyocarditis (EMC) virus. The ED50 for this effect is 1.50-15.0 pg/mL

SDS-PAGE View Larger

1 μg/lane of Recombinant Human IFN-alpha H2/IFNA14 Protein (Catalog # 11019-IF) was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by silver staining, showing bands at 22-26 kDa, respectively.

Reconstitution Calculator

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Background: IFN-alpha H2/IFNA14

Interferons (IFN) are a family of cytokines with potent antiviral, antiproliferative and immunomodulatory properties, classified based on their binding specificity to cell surface receptors (1). Human IFNA2 was originally cloned in the early ‘80s and now more than a dozen closely related IFN alpha subtypes have been identified in both the human and mouse genome, each sharing about 80% amino acid (aa) sequence homology (2-4). Structurally, type I IFNs belong to the class of five helical‑bundle cytokines, with the IFNA subtypes containing 2 conserved disulfide bonds (5). The extracellular domain (ECD) of mature human IFNA14, shares 58% aa sequence identity with mouse IFNA14. The type I IFNs bind to the interferon alpha receptor (IFNAR), which consists of two subunits: IFNAR1 (alpha‑subunit) and IFNAR2 (beta-subunit) (6, 7). Individual IFNA subtypes are known to display unique efficacies to viral protection, and IFNA14 has been shown to be a strong inducer of IFN-stimulated genes and anti-viral protection (8). IFNA14 has been shown to be potent against HIV-1 by up‑regulating the transcription of two intrinsic restriction factors with well-established anti-HIV-1 activity, MX2 and tetherin (9).

References
  1. Pestka, S. et al. (1987) Annu Rev Biochem. 56:727.
  2. Goeddel, D.V. et al. (1980) Nature 287:411.
  3. Matsumiya, T. et al. (2007) J. Immunol. 179:4542.
  4. Schreiber, G. and J. Piehler (2015) Trends Immunol. 36:139.
  5. Wittling, M.C. et al. (2021) Front Immunol. 11:605673.
  6. van Pesch, V. et al. (2004) J. Virol. 78:8219.
  7. James, C.M. et al. (2007) Vaccine. 25(10):1856.
  8. Moll, H.P. et al. (2011) Cytokine. 53:52.
  9. Lavender, K.J. et al. (2016) J Virol. 90:6001.
Long Name
Interferon alpha H2
Entrez Gene IDs
3448 (Human); 404549 (Mouse)
Alternate Names
IFNA14; IFNalpha H2; IFN-alpha H2; IFN-alpha-14; IFN-alphaH; interferon alpha-14; Interferon alpha-H; Interferon lambda-2-H; interferon, alpha 14; LeIF H; LEIF2H; MGC125756; MGC125757

FAQs

No product specific FAQs exist for this product, however you may

View all Proteins and Enzyme FAQs

Reviews for Recombinant Human IFN-alpha H2/IFNA14 Protein, CF

There are currently no reviews for this product. Be the first to review Recombinant Human IFN-alpha H2/IFNA14 Protein, CF and earn rewards!

Have you used Recombinant Human IFN-alpha H2/IFNA14 Protein, CF?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review